TD Asset Management
ARRY

TD Asset Management’s Array Biopharma Inc ARRY Stock Holding History

TD Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-40,064
Closed -$1.86M – 1395
2019
Q2 		$1.86M Sell
40,064
-204,697
-84% -$5.75M ﹤0.01% 921
2019
Q1 		$5.97M Buy
244,761
+98,812
+68% +$2.06M 0.01% 649
2018
Q4 		$2.08M Buy
145,949
+35,500
+32% +$538K ﹤0.01% 906
2018
Q3 		$1.68M Sell
110,449
-10,700
-9% -$164K ﹤0.01% 1039
2018
Q2 		$2.03M Buy
121,149
+1,100
+0.9% +$17.5K ﹤0.01% 953
2018
Q1 		$1.96M Buy
120,049
+43,600
+57% +$698K ﹤0.01% 892
2017
Q4 		$979K Sell
76,449
-7,500
-9% -$85.3K ﹤0.01% 1056
2017
Q3 		$1.03M Buy
83,949
+33,065
+65% +$307K ﹤0.01% 1021
2017
Q2 		$426K Sell
50,884
-61,484
-55% -$503K ﹤0.01% 1212
2017
Q1 		$1M Buy
112,368
+4,500
+4% +$47.9K ﹤0.01% 1035
2016
Q4 		$948K Buy
+107,868
New +$794K ﹤0.01% 1039
2015
Q4 		– Sell
-222,100
Closed -$1.01M – 1401
2015
Q3 		$1.01M Sell
222,100
-88,700
-29% -$526K ﹤0.01% 920
2015
Q2 		$2.24M Sell
310,800
-19,600
-6% -$145K ﹤0.01% 836
2015
Q1 		$2.44M Sell
330,400
-9,300
-3% -$66.2K ﹤0.01% 807
2014
Q4 		$1.61M Buy
339,700
+12,400
+4% +$49K ﹤0.01% 863
2014
Q3 		$1.17M Sell
327,300
-11,200
-3% -$44.1K ﹤0.01% 881
2014
Q2 		$1.54M Sell
338,500
-23,800
-7% -$98.4K ﹤0.01% 854
2014
Q1 		$1.7M Buy
362,300
+28,800
+9% +$145K ﹤0.01% 847
2013
Q4 		$1.67M Buy
333,500
+6,300
+2% +$34.3K ﹤0.01% 832
2013
Q3 		$2.04M Buy
327,200
+103,100
+46% +$612K ﹤0.01% 799
2013
Q2 		$1.02M Buy
+224,100
New +$1.21M ﹤0.01% 843

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

TD Asset Management's ARRY Position: Q3 2019 in Review

TD Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 40,064 shares — an estimated $1.86M sold.

TD Asset Management first reported a position in ARRY in Q2 2013 and held it in 21 quarters. The position peaked at $5.97M in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • TD Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • TD Asset Management sold 40,064 Array Biopharma Inc shares in Q3 2019, an estimated $1.86M.
  • TD Asset Management first reported a position in Array Biopharma Inc in Q2 2013 and held it in 21 quarters.
  • TD Asset Management's Array Biopharma Inc position peaked at $5.97M in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on TD Asset Management's 13F filing for Q3 2019, filed 7 Nov 2019.